The target comes before the result
Polymerase chain reaction (PCR) amplifies a selected DNA sequence. The target, sample and analytical method define what a result can establish. A result for one target is not a broad screen for every microorganism or contaminant.
PCR-based methods can provide evidence about specified genetic material. They do not measure chemical purity, total material weight, sterility or endotoxin. Begin with the target named in the original report. NHGRI's PCR overview explains the underlying amplification concept.
Four terms you may see on a report
| Method | What distinguishes it | What to ask |
|---|---|---|
| Conventional PCR | The amplification product is examined after the reaction, often as an endpoint result. | What target and detection method were used? Is the result qualitative rather than a calibrated quantity? |
| Real-time PCR / qPCR | Fluorescence is monitored during amplification. With an appropriate calibration or analysis framework, the data can support quantification. | Was a quantity actually assigned, on what basis, and with what units and uncertainty? |
| Digital PCR / dPCR | The sample is partitioned into many reactions. Positive and negative partitions support a statistical estimate of target concentration. | What target, partition volume and analysis were used? How were detection limits and uncertainty established? |
| Reverse-transcription PCR | RNA is converted into complementary DNA, or cDNA, before PCR amplification. | Was the measurement of an RNA target, and how were extraction and reverse transcription assessed? |
These categories can overlap. Reverse transcription can precede conventional PCR, qPCR or dPCR; it is a sample-conversion step rather than a competing readout. See NLM's reverse-transcription PCR definition, NIST's explanation of fluorescence-based qPCR and NIST's digital PCR overview.
Clarify what “RT-PCR” means
The letters can be confusing: some reports use “RT” to mean reverse transcription, while informal descriptions sometimes use it for real-time. Ask the laboratory to spell out the method instead of interpreting the abbreviation alone.
qPCR identifies quantitative real-time PCR; RT-qPCR makes the reverse-transcription step explicit. A real-time instrument does not, by itself, make every reported result quantitative. The MIQE 2.0 reporting guidelines use distinct terms for qPCR and RT-qPCR and emphasize the information needed to assess the result.
Controls explain whether a result is interpretable
- Positive control: provides evidence that the expected target can be detected by the relevant assay system.
- No-template control: helps reveal contamination introduced through the amplification reagents or reaction setup.
- Extraction blank: helps identify contamination associated with sample extraction.
- Process or recovery control: addresses performance through specified sample-processing stages.
- No-reverse-transcription control: in an RNA assay, helps distinguish unwanted DNA-derived signal from signal dependent on reverse transcription.
- Inhibition assessment: examines whether sample components interfere with amplification or reverse transcription.
These controls do different jobs. A successful amplification control does not automatically prove that extraction recovered the target or that the sample had no inhibition. The report should identify the controls used and whether they supported interpretation. CDC's molecular testing quality-control discussion illustrates these distinctions in a specific sample setting; the suitable control plan still depends on the actual assay and material.
Read detection limits and quantities carefully
Not detected means the named target was not detected under that method's conditions and reporting rules. It does not establish that the target is absent in every portion of the material. Sample recovery, inhibition, target specificity and the reporting limit affect interpretation.
A Cq or Ct value is an amplification-cycle measurement, not a universal concentration. Do not compare values across different assays as though they share a common scale. For a quantitative claim, ask about the calibration or analysis, units, reportable range and uncertainty. Digital PCR can estimate concentration without a standard curve, but it still depends on a suitable assay and analysis; it is not free of measurement limitations.
Detection of genetic material also does not, by itself, establish that an organism is viable. CDC distinguishes genetic detection from recovery of a viable organism. A PCR result therefore should not replace the separate questions addressed by sterility and endotoxin testing.
Five questions for the laboratory
- Which genetic target and sample type were examined?
- Which PCR method was used, and was reverse transcription involved?
- What controls, recovery checks and inhibition assessments supported the result?
- Is the result qualitative or quantitative, with what reporting limit and units?
- What limitations or qualifications appear on the original report?
This is general method education, not a claim that PCR is included in our testing program or that any material is suitable for human or veterinary use. Check the actual batch report for the tests performed and the COA guide for help reading its fields.